According to Palatin Technologies's latest financial reports and stock price the company's current number of shares outstanding is 14,097,757. At the end of 2023 the company had 14,097,757 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 14.09 M | 30.5% |
2022 | 10.8 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 16,975.06% | ๐บ๐ธ USA |
AstraZeneca AZN | 3,098,000,000 | 21,875.13% | ๐ฌ๐ง UK |
Neurocrine Biosciences
NBIX | 97,900,000 | 594.44% | ๐บ๐ธ USA |
MediciNova MNOV | 49,046,246 | 247.90% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | 17,380,000 | 23.28% | ๐บ๐ธ USA |
Dicerna Pharmaceuticals DRNA | 73,916,400 | 424.31% | ๐บ๐ธ USA |
ANI Pharmaceuticals ANIP | 18,883,000 | 33.94% | ๐บ๐ธ USA |
GlycoMimetics
GLYC | 64,349,709 | 356.45% | ๐บ๐ธ USA |
Ardelyx ARDX | 222,782,229 | 1,480.27% | ๐บ๐ธ USA |